33 |
Clinical features and treatment outcomes of lymphoplasmacy..
|
2013-09-16 |
1243 |
32 |
Clinical features and prognostic relevance of ovarian invo..
|
2013-09-16 |
1004 |
31 |
When do we need central nervous system prophylaxis in pati..
|
2013-09-16 |
1053 |
30 |
(18)F-FDG uptake and its clinical relevance in primary gas..
|
2013-09-16 |
1084 |
29 |
Improved treatment outcome of primary mediastinal large B-..
|
2013-09-16 |
1261 |
28 |
Phase II trial of concurrent radiation and weekly cisplati..
|
2013-09-16 |
1252 |
27 |
Phase II trial of concurrent radiation and weekly cisplati..
|
2013-09-16 |
961 |
26 |
Clinical features and prognostic factors of patients with ..
|
2013-09-16 |
867 |
25 |
Clinical Features and Treatment Outcomes of Non-Hodgkin..
|
2013-09-16 |
914 |
24 |
Relapsed or refractory nongastric marginal zone B-cell lym..
|
2013-09-16 |
1077 |